Source: Annual Congress 2004 - Clinical aspects of OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. R. L. Schwartz, M. J. Thorpy, J. Black, M. K. Erman (Oklahoma City, Bronx, Stanford, San Diego, United States Of America). Tolerability of modafinil in disorders of sleep and wakefulness. Eur Respir J 2004; 24: Suppl. 48, 798

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of modafinil as an adjunctive therapy for excessive sleepiness associated with obstructive sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 116s Year: 2004 Feasibility and patient tolerability of transcutaneous electrical stimulation in obstructive sleep apnoea Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 Differences in the daytime sleepiness between sleep apnoea and hypersomnia patients Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Is waking electroencephalographic activity a predictor of daytime sleepiness in sleep-related breathing disorders? Source: Eur Respir J 2002; 19: 645-652 Year: 2002 Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 The efficacy of oral appliance in patients with severe obstructive sleep apnea Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014 Management of insomnia in sleep disordered breathing Source: Eur Respir Rev, 28 (153) 190080; 10.1183/16000617.0080-2019 Year: 2019 Efficacy and safety of single-use suvorexant for insomnia during in-laboratory polysomnography in patients with obstructive sleep apnea: A feasibility study Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Cerebral oxygenation during REM sleep in obstructive sleep apnoea is associated with daytime neuropsychological function Source: Eur Respir J 2004; 24: Suppl. 48, 444s Year: 2004 Sleep apnea as a cause of sleep misperception in elderly insomnia patients Source: International Congress 2017 – Phenotyping obstructive sleep apnoea Year: 2017 The relationship between anxiety, depression and subjective sleep quality on sleep apnea patients Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Rapid eye movement sleep behaviour disorder and obstructive sleep apnoea Source: 5th Sleep and Breathing Conference Year: 2019 Insomnia in sleep disordered breathing Source: International Congress 2017 – Sleep and Breathing Year: 2017 Relation between sleep bruxism and sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 494s Year: 2002